相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia
F. Pea et al.
INFECTION (2014)
An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
Gloria Wong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Review of Continuous-Infusion Vancomycin
V. Paul DiMondi et al.
ANNALS OF PHARMACOTHERAPY (2013)
Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
S. J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Clinical Validation of the Analysis of Linezolid and Clarithromycin in Oral Fluid of Patients with Multidrug-Resistant Tuberculosis
M. S. Bolhuis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
Gloria Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2013)
Aminoglycosides in Septic Shock
Alexandre Boyer et al.
DRUG SAFETY (2013)
Vancomycin therapeutics and monitoring: a contemporary approach
M. L. Avent et al.
INTERNAL MEDICINE JOURNAL (2013)
Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion
J. J. De Waele et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects
Els Ampe et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
Dario Cattaneo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
Yoko Nukui et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
First liquid chromatography method for the simultaneous determination of levofloxacin, pazufloxacin, gatifloxacin, moxifloxacin and trovafloxacin in human plasma
Joana Sousa et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots
Lorena Baietto et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Continuous intravenous administration of vancomycin in medical intensive care unit patients
Bernd Saugel et al.
JOURNAL OF CRITICAL CARE (2013)
Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary?
Marco Falcone et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin
Yoshiko Takahashi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
Kazuaki Matsumoto et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations
Dagan O. Lonsdale et al.
JOURNAL OF NEUROSURGERY (2013)
Benefits of Therapeutic Drug Monitoring of Vancomycin: A Systematic Review and Meta-Analysis
Zhi-Kang Ye et al.
PLOS ONE (2013)
What Proportion of Vancomycin Trough Levels Are Drawn Too Early? Frequency and Impact on Clinical Actions
Aileen P. Morrison et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Successful Long-Term Treatment of Cerebral Nocardiosis with Unexpectedly Low Doses of Linezolid in an Immunocompromised Patient Receiving Complex Polytherapy
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Optimal Meropenem Concentrations To Treat Multidrug-Resistant Pseudomonas aeruginosa Septic Shock
Fabio Silvio Taccone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis
D. H. Vu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Therapeutic drug monitoring of antimicrobials
Jason A. Roberts et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients Association Between Augmented Renal Clearance and Low Trough Drug Concentrations
Andrew A. Udy et al.
CHEST (2012)
Outcomes of Extended-Infusion Piperacillin-Tazobactam: A Retrospective Analysis of Critically Ill Patients
Grace C. Lee et al.
CLINICAL THERAPEUTICS (2012)
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: A multicentre pharmacokinetic study
Darren M. Roberts et al.
CRITICAL CARE MEDICINE (2012)
Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation
Janattul-Ain Jamal et al.
CURRENT OPINION IN CRITICAL CARE (2012)
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance
Andrew A. Udy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method
Mieke Carlier et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodialtration
Judith M. Wenisch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis
Maria Adriana Cataldo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
Federico Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients
Nadezda Petejova et al.
JOURNAL OF CHEMOTHERAPY (2012)
A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection
Scott E. Briscoe et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation
Kiran Shekar et al.
JOURNAL OF CRITICAL CARE (2012)
Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans
Kavitha K. Prabaker et al.
JOURNAL OF HOSPITAL MEDICINE (2012)
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
Fekade Bruck Sime et al.
ANNALS OF INTENSIVE CARE (2012)
The relationship between trough concentration of vancomycin and effect on methicillin-resistant Staphylococcus aureus in critically ill patients
J. Y. Cheong et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2012)
Simple and sensitive determination of sparfloxacin in pharmaceuticals and biological samples by immunoassay
Hua-Jin Zeng et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2012)
TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient
Federico Pea et al.
ANNALS OF PHARMACOTHERAPY (2011)
Pharmacokinetics of Ciprofloxacin and Its Penetration into Bronchial Secretions of Mechanically Ventilated Patients with Chronic Obstructive Pulmonary Disease
Paschalina Kontou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens
Jason A. Roberts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Applying New Diagnostic Criteria for Acute Kidney Injury To Facilitate Early Identification of Nephrotoxicity in Vancomycin-Treated Patients
Emi Minejima et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial
John A. Bosso et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations
Jean-Marie Conil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
Ravina Kullar et al.
CLINICAL INFECTIOUS DISEASES (2011)
Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems
M. Vading et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Dosing of Antibiotics in Critically Ill Patients Undergoing Renal Replacement Therapy
Jan T. Kielstein et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
A higher dose of vancomycin in continuous infusion is needed in critically ill patients
A. Jeurissen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill Intensive Care Unit patients
Haiyan Dong et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Simultaneous determination of eight β-lactam antibiotics in human serum by liquid chromatography-tandem mass spectrometry
Tomofumi Ohmori et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction
Yasuhiro Tsuji et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2011)
Development and validation of an ultra performance liquid chromatography-tandem mass spectrometry method for the quantification of daptomycin in human plasma
Fotini N. Bazoti et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Lucie Seyler et al.
CRITICAL CARE (2011)
Increasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity
Lindsey Pritchard et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes
Vincent H. Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function
F. Lamoth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Determination of Ciprofloxacin in Dried Blood Spots for Therapeutic Drug Monitoring
Mutasim Al-Ghazawi et al.
CHROMATOGRAPHIA (2010)
Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
Sujata M. Bhavnani et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pharmacokinetics of linezolid in septic patients with and without extended dialysis
Stefanie Swoboda et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections
Elizabeth D. Hermsen et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction
Kazuaki Matsumoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Support for higher ciprofloxacin AUC24/MIC targets in treating Enterobacteriaceae bloodstream infection
Sheryl A. Zelenitsky et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Potential Subtherapeutic Linezolid and Meropenem Antibiotic Concentrations in a Patient With Severe Burns and Sepsis
M. -J. Hallam et al.
JOURNAL OF BURN CARE & RESEARCH (2010)
Determination of Linezolid in Human Plasma by High-Performance Liquid Chromatography With Ultraviolet Detection
Dario Cattaneo et al.
THERAPEUTIC DRUG MONITORING (2010)
Limited Sampling Strategies for Therapeutic Drug Monitoring of Linezolid in Patients With Multidrug-Resistant Tuberculosis
Jan-Willem C. Alffenaar et al.
THERAPEUTIC DRUG MONITORING (2010)
Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic Patients
Isabelle K. Delattre et al.
THERAPEUTIC DRUG MONITORING (2010)
Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Prospective monitoring of cefepime in intensive care unit adult patients
Thomas M. Chapuis et al.
CRITICAL CARE (2010)
Vancomycin Ototoxicity: a Reevaluation in an Era of Increasing Doses
Avisheh Forouzesh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Is Vancomycin Ototoxicity a Significant Risk?
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Continuous Infusion of Vancomycin Less Effective and Safe than Intermittent Infusion, Based on Pharmacodynamic and Pharmacokinetic Principles
Prachant Nannan Panday et al.
CLINICAL INFECTIOUS DISEASES (2009)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Principles of antibacterial dosing in continuous renal replacement therapy
Gordon Choi et al.
CRITICAL CARE MEDICINE (2009)
Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem
Scott A. Weisenberg et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Pharmacokinetic evaluation of linezolid in patients with major thermal injuries
A. M. Lovering et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The Use of Extended-Interval Aminoglycoside Dosing Strategies for the Treatment of Moderate-to-Severe Infections Encountered in Critically III Surgical Patients
Eric W. Mueller et al.
SURGICAL INFECTIONS (2009)
The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data
Alexander Melamed et al.
CRITICAL CARE (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pharmacokinetic variability of extended interval tobramycin in burn patients
David Bracco et al.
BURNS (2008)
Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam:: Implications on the appropriateness of the resistance breakpoint
Vincent H. Tam et al.
CLINICAL INFECTIOUS DISEASES (2008)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study
Arthur R. H. van Zanten et al.
JOURNAL OF CRITICAL CARE (2008)
Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure
Yasuhiro Tsuji et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2008)
Suboptimal Aminoglycoside Dosing in Critically Ill Patients
Rhonda S. Rea et al.
THERAPEUTIC DRUG MONITORING (2008)
Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms
Sunil V. Bhat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Effective separation and simultaneous determination of seven fluoroquinolones by capillary electrophoresis with diode-array detector
Han-wen Sun et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
Meghan N. Jeffres et al.
CLINICAL THERAPEUTICS (2007)
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
Chonghua Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Appropriate pharmacokinetic index for outcome in staphylococcus aureus pneumonia
Brian A. Potoski et al.
CHEST (2007)
Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters
John E. Murphy et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia -: Specific evaluation of vancomycin pharmacokinetic indices
Meghan N. Jeffres et al.
CHEST (2006)
Increased amikacin dosage requirements in burn patients receiving a once-daily regimen
J. M. Conil et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective
Federico Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Reliable new high-performance liquid chromatographic method for the determination of ciprofloxacin in human serum
IM van Geijlswijk et al.
THERAPEUTIC DRUG MONITORING (2006)
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia
G Sakoulas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient
F Pea et al.
CLINICAL INFECTIOUS DISEASES (2006)
Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients
N Simon et al.
CLINICAL PHARMACOKINETICS (2006)
Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdorninal sepsis
A Gous et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
BP Howden et al.
CLINICAL INFECTIOUS DISEASES (2004)
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 cases
F Pea et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
In vivo pharmacodynamic activity of daptomycin
N Safdar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacodynamics and dosing of aminoglycosides
J Turnidge
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment
JF Wilson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Pharmacokinetic dosing of aminoglycosides: A controlled trial
C Bartal et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial
DJ Stalker et al.
CLINICAL PHARMACOKINETICS (2003)
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme
CR Rayner et al.
CLINICAL PHARMACOKINETICS (2003)
Vancomycin therapeutic drug monitoring: Is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire
CM Tobin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients
F Pea et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Evaluation of four once-daily aminoglycoside dosing nomograms
AW Wallace et al.
PHARMACOTHERAPY (2002)
Pharmacodynamics of cefepime in patients with Gram-negative infections
VH Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Can PK/PD be used in everyday clinical practice
F Scaglione
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Pharmacokinetics and pharmacodynamics of fluoroquinolones
KA Rodvold et al.
PHARMACOTHERAPY (2001)
Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study
M Wysocki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs
DS Streetman et al.
PHARMACOTHERAPY (2001)
分享论文
